News & Perspective

Jun 28, 2011

Jun 28, 2011

Federal review outlines new flu vaccine investments, challenges

(CIDRAP News) – The price-tag for federal investments in new flu vaccine technology has been difficult to get a handle on, but yesterday in a review for Congress the Government Accountability Office (GAO) put the number at $2.1 billion since fiscal year 2005.